[go: up one dir, main page]

WO2024089183A1 - Dispositif et système de collecte de particules d'aérosol et de préparation de l'échantillon pour analyse - Google Patents

Dispositif et système de collecte de particules d'aérosol et de préparation de l'échantillon pour analyse Download PDF

Info

Publication number
WO2024089183A1
WO2024089183A1 PCT/EP2023/079951 EP2023079951W WO2024089183A1 WO 2024089183 A1 WO2024089183 A1 WO 2024089183A1 EP 2023079951 W EP2023079951 W EP 2023079951W WO 2024089183 A1 WO2024089183 A1 WO 2024089183A1
Authority
WO
WIPO (PCT)
Prior art keywords
aqueous solution
sampling device
dissolvable
filter element
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2023/079951
Other languages
English (en)
Inventor
Tobias BROGER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avelo Ag
Original Assignee
Avelo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avelo Ag filed Critical Avelo Ag
Publication of WO2024089183A1 publication Critical patent/WO2024089183A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N1/2202—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
    • G01N1/2205—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N1/2202—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
    • G01N1/2208—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling with impactors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N1/2247—Sampling from a flowing stream of gas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B2010/0083—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements for taking gas samples
    • A61B2010/0087—Breath samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N1/2202—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
    • G01N2001/222—Other features
    • G01N2001/2223—Other features aerosol sampling devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N2001/2244—Exhaled gas, e.g. alcohol detecting
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N1/2247—Sampling from a flowing stream of gas
    • G01N2001/227—Sampling from a flowing stream of gas separating gas from solid, e.g. filter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/22—Devices for withdrawing samples in the gaseous state
    • G01N2001/2285—Details of probe structures
    • G01N2001/2288—Filter arrangements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4055—Concentrating samples by solubility techniques
    • G01N2001/4061—Solvent extraction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration

Definitions

  • the present invention relates to a device and system for collecting aerosol particles and preparing the sample for analysis and detection of biomarkers.
  • Such particles are suspended in air in the form of an aerosol and may carry pathogens or biomarkers.
  • the source of the aerosol can be breath of a human or animal or the environment.
  • Such a device and system is configured for the improved collection, preservation, preparation, concentration and rapid and complete release of pathogens and biomarkers for the subsequent analysis with immunoassays or molecular assays for the detection of such pathogens and biomarkers.
  • TPP High priority target product profiles
  • VOCs volatile organic compounds
  • US10413215 electronic noses or mass spectrometry
  • WO2017187141 mass spectrometry
  • the molecular entities of the detected VOCs and their origin are usually not defined and thus their relevance for a particular disease is unclear or even biologically implausible which led to low specificities, making VOC based systems inappropriate for clinical diagnosis.
  • mass spectrometers remain expensive, are relatively large instruments and therefore most likely not feasible for point-of-care use.
  • collected VOCs are not compatible with state-of-the art laboratory diagnostic methods such as polymerase chain reaction (PCR) and immunoassays.
  • PCR polymerase chain reaction
  • Aerosols contain biologically plausible, nonvolatile pathogens, such as entire bacteria, virus, fungi and pathogen biomarkers such as nucleic acids (such as DNA and RNA) or pathogen antigens.
  • Aerosols are a suspension of fine particles, particulate matter, “droplet nuclei” or liquid droplets (subsequently called “aerosol particles”) in air.
  • an aerosol is a heterogeneous mixture of particles together with the gas or gas mixture surrounding them. Exhaled aerosol particles occur in multiple size modes that are associated with different generation sites and production mechanisms in the respiratory tract (Wang et al. Science. 2021;373(6558)).
  • Aerosol particles are typically ⁇ 100 pm in diameter and may contain infectious bacteria and viruses and studies have shown that pathogens are enriched in small aerosol particles, typically ⁇ 5 pm (Gralton et al. J Med Virol. 2013 ;85(12):2151 , Fennelly et al. Am J Respir Crit Care Med 2004;169(5):604). Aerosols that contain biological material such as cells like bacteria, or virus, biological molecules, by-products of metabolism and cell fragments are often referred to as bioaerosols which origin from a biological source or may affect a biological target. Many studies showed that respiratory infectious diseases including RSV (Kulkami et al. Am J Respir Crit Care Med.
  • the background art fails to teach or suggest the reproducible collection and elution of biomarkers in aerosols. Further the background art fails to teach a device or system that combines efficient aerosol particle collection on filters paired with simple and complete in situ extraction or elution of said aerosol particles in a suitable volume of liquid without moving, removing and/or dipping said filter.
  • US2015/0377748 describes a breath analysis system with a filter assembly that is movable between a breath capture position and an analysis position that does not allow for in situ elution and extraction of the collected breath markers.
  • WO 2022/079195 relates to a collection device for collection of particles and presentation of collected particles for analysis. Both systems describe on-board analysis and do not describe a releasably engageable tube for in situ elution and extraction of the collected markers from the collection element to retrieve a sample for biobanking, transportation and/or subsequent processing and analysis with state-of-the art laboratory tests on state-of-the-art laboratory analyzers.
  • WO 2021/242907 relates to an insert for a wearable mask worn by an individual over the mouth and nose, whereas the test substrate is located inside the mask, and whereas the test substrate is removed from the mask and inserted into a vial for further testing.
  • This requires manual handling of the substrate and poses a high risk of contamination of the sample with biomarkers and pathogens from the environment and at the same time puts the user at risk when manually handling infectious material on the substrate.
  • Inefficiency and resulting low sensitivity is also a limitation in another prior art examples due to the low collection and concentration efficiency (EP 1 377 815).
  • WO 2012/024407 describes an aerosol collection system that uses a nanofiber mat with a plurality of electrospun nanofibers formed as a filter to collect aerosols.
  • a pump is used to entrain air-borne particles in a gas stream.
  • WO 2013/132085 relates to a portable sampling device for aerosols.
  • An electrostatic filter membrane is used to collect aerosols from exhaled breath of a subject.
  • baffle plates inside the sampling device are provided to obtain a non-straight gas flow through the device.
  • the device is sealed and then sent to a laboratory for further sensor based analysis. Solvents are used for extraction.
  • US 10,080,857 describes a system for breath sample collection and analysis. A subject exhales into a mouthpiece connected to a sample collector.
  • the sample collector uses a nozzle and contains a liquid buffer downstream of the nozzle which collects the analyte. After use, the mouthpiece is disconnected, the sample collector is sealed and then transferred to a diagnostic device which analyses the analyte.
  • the present invention relates to a device and system for collecting aerosol particles and preparing the sample for analysis.
  • a device and system for collecting aerosol particles and preparing the sample for analysis Although reference is made herein to “human breath”, it is contemplated that the present invention would also be suitable for non-human animals.
  • the present invention may also be used to collect particles from air in a room, for example, in which human beings gathered in order to test the air exhaled by the human beings for pathogens or biomarkers possibly present in the air.
  • the present invention may also be used to sample aerosol from livestock and the environment.
  • the present invention provides such a device and system to collect, preserve, concentrate and release pathogen-specific biomarkers from breath aerosol particles for the subsequent analysis with immunoassays and molecular assays for the clinical diagnosis of respiratory tract infections in humans.
  • the sampling device comprises an aqueous solution dissolvable element and a filter element in spatial proximity installed in the housing in the flow path of aerosol.
  • a dissolvable material is defined as a material of which 4 mg dissolve within less than 15 minutes at ambient temperature (23° C), ambient pressure (1 atm) and in 1.6 mL water without movement of the water by stirring, shaking and the like.
  • the sampling device for the collection of aerosol particles contained in an aerosol sample comprises a housing, which comprises a flow inlet for the inflow of an aerosol sample into the housing and a flow outlet for the outflow of the aerosol sample out of the housing.
  • the flow of the aerosol sample from the flow inlet to the flow outlet defines a flow path of the aerosol sample.
  • the housing defines, respectively delimits, a flow path for the aerosol sample from the flow inlet to the flow outlet.
  • the sampling device may further comprise a filter assembly to collect aerosol particles contained in the aerosol sample.
  • the filter assembly includes an aqueous solution dissolvable element and a filter element.
  • the filter assembly is preferably at least partially arranged inside the housing between the flow inlet and the flow outlet and in the flow path of the aerosol sample.
  • a system for the collection and elution of aerosol particles contained in an aerosol sample according to the invention may comprise a sampling device as described in any of the embodiments herein, and an elution device which is releasably connectable to the housing by means of the engagement means of the sampling device for introducing an aqueous solution into the housing, for dissolving the aqueous solution dissolvable element upon contact with the aqueous solution, and upon dissolution of the aqueous solution dissolvable element, for submerging the filter element into the aqueous solution to thus retrieve the aerosol particles captured on the aqueous solution dissolvable element and the filter element and receiving the eluate
  • both the aqueous solution dissolvable element and the filter element are arranged inside the housing between the flow inlet and the flow outlet and in the flow path of the aerosol sample. Therefore, both the aqueous solution dissolvable element and the filter element are exposed to the aerosol sample when it flows through the flow path.
  • the aqueous solution dissolvable element is airtight.
  • airtight for an element such as the aqueous solution dissolvable element may preferably mean that air at atmospheric pressure does not pass the airtight element. For example, if a person exhales into the flow path (e.g. via the flow inlet), the exhaled air does not pass through the airtight aqueous solution dissolvable element.
  • the airtight element may be configured such that air at a pressure of 1.2 bar and at 23 °C does not pass through the element with a rate higher than 1 mL per hour, in particular higher than 1 mL per day.
  • the filter element is air permeable. For example this may mean that if a person exhales into the flow path (e g. via the flow inlet), the exhaled air passes through the air permeable filter element.
  • such an air permeable element allows air at a pressure of 1.2 bar and at 23 °C to pass through the element with a rate of more than 1 mL/h, in particular more than 1 mL/min, more particular more than 1 L/min.
  • an area of the filter element is greater than an area of the aqueous solution dissolvable element. That is, a total surface area of the filter element may be greater than a total surface area of the aqueous solution dissolvable element. It is understood that the total surface area refers to the area of the full surface of the filter element.
  • the filter element is at least partially arranged radially outwardly from the aqueous solution dissolvable element.
  • radially outwardly refers to a direction along a plane along which the aqueous solution dissolvable element extends. Further, it indicates a maximum distance between the center of the aqueous solution dissolvable element towards the outer peripheral limit of the aqueous solution dissolvable element.
  • the aqueous solution dissolvable element has a circular cross section it refers to the radius of the circle.
  • the aqueous solution dissolvable element has a rectangular cross section it refers to half the diagonal extending from the center to an edge of the rectangle.
  • the filter element is ring-shaped and/or circular, and the aqueous solution dissolvable element is geometrically arranged completely inside the filter element. In some embodiments, the aqueous solution dissolvable element is peripherally circumferentially surrounded by the filter element.
  • a diameter of the filter assembly is between 5 and 50 mm.
  • the term “diameter” as used herein refers to length of a line extending through the filter assembly center from which two opposing peripheral limits of the filter assembly have the largest distance from each other.
  • the filter element has for example a circular cross section it refers to the diameter of the circle.
  • the filter element has for example a rectangular cross section it refers to the diagonal extending edge to edge the rectangle.
  • the filter element and the aqueous solution dissolvable element at least partially overlap.
  • the filter element and the aqueous solution dissolvable element are bonded.
  • the filter assembly further includes a retainer element which retains the filter element and/or the aqueous solution dissolvable element in place.
  • the retainer element is clampingly engageable with a filter holder.
  • the sampling device further comprises an engagement means for releasably engaging an elution device with the housing, for introducing an aqueous solution into the housing, for submerging the aqueous solution dissolvable element and the filter element into the aqueous solution, and to thus dissolve the aqueous solution dissolvable element upon contact with an aqueous solution
  • the engagement means includes a thread.
  • the engagement means is an internal thread provided on an inner surface of the housing.
  • the engagement means is configured such that a laboratory tube containing an aqueous solution and preferably normally used in preparation for an assay selected from the group consisting of a nucleic acid amplification test (NAAT), a PCR assay, an isothermal amplification assay, a DNA hybridization assay, a CRISPR-based assay, a sequencing assay and an immunoassay, is releasably connectable to the housing.
  • a normally used laboratory tube may for example be a Copan eNAT tube with 12 mm diameter and 80 mm long.
  • a thread is provided on the housing upstream of the aqueous solution dissolvable element.
  • the thread may be engageable with a threaded closure to close off the flow inlet of the housing.
  • the aqueous solution dissolvable element comprises a polymer selected from the group consisting of polyvinyl alcohol (PVA), chitosan, polyethylene oxide (PEO), pullulan, polyvinylpyrrolidone (PVP), polyvinyl acrylic acid (PVAc), poly methacrylic acid (PMAc), methyl acrylate copolymers, hydroxypropyl methylcellulose phthalate (HPMCP), and a combination thereof.
  • PVA polyvinyl alcohol
  • PEO polyethylene oxide
  • pullulan polyvinylpyrrolidone
  • PVP polyvinyl acrylic acid
  • PMAc poly methacrylic acid
  • HPPMCP hydroxypropyl methylcellulose phthalate
  • the aqueous solution dissolvable element is a membrane, foil or film with a thickness in a range between 0.5 pm to 50 pm.
  • the filter element is fully or partially dissolvable in an aqueous solution.
  • the filter element comprises fibers. Such fibers increase the surface area and help to collect more aerosol particles.
  • the filter element comprises two layers of fibers.
  • the fibers have a diameter in the range between 20 nm to 1 gm.
  • the filter element further comprises a polymer support mesh having a thickness in a range between 40 pm to 500 pm to support the fibers.
  • dissolution of the aqueous solution dissolvable element and/or the filter element in the aqueous solution is triggered by a change in pH-value. That is, in certain embodiments, the aqueous solution dissolvable element is configured such that its dissolution can be triggered by a change of pH-value.
  • the aqueous solution dissolvable element and/or filter element contain assay reagents selected from the group consisting of control nucleic acid, primers, probes, nucleotides, enzymes, salts, capture beads and combinations thereof
  • the sampling device is a hand-held sampling device for the collection of aerosol particles present in a human breath bioaerosol.
  • the elution device is a tube having a closed end and an open end opposite the closed end, and wherein an external thread is provided at the open end of the elution device which is engageable with an internal thread of the housing of the sampling device.
  • the elution tube has a sample volume in the range of 0.2 ml to 20 ml, and/or a diameter in the range of 8 mm to 30 mm.
  • the aqueous solution dissolvable element is a circular foil positioned in the center surrounded by a ring-shaped filter element.
  • an aerosol defined as particles in air, enters the sampling device. Large particles impact with the airtight dissolvable, centric membrane based on inertial impaction which constitutes a first collection or filter stage.
  • the aqueous solution dissolvable element dissolves in an aqueous solution upon contact which creates a centric opening so that the outer filter element is submerged in said aqueous solution
  • An advantage of this is that the particles trapped on the aqueous solution dissolvable element are completely released into solution upon dissolution of said aqueous solution dissolvable element.
  • Another advantage is that the particles captured by the ring-shaped filter element are eluted from both sides of the filter element due to the centric opening that is formed after dissolution of the aqueous solution dissolvable element. Taken together this leads to very high elution recoveries of captured particles, pathogens and biomarkers.
  • Another advantage is the spatial closeness of the aqueous solution dissolvable element and the filter element which facilitates elution in a small liquid volume. This permits concentrating of particles, pathogens and/or biomarkers from a relatively large air volume in a small volume of liquid by the sampling device to reach sufficient concentrations for subsequent detection with molecular assays and/or immunoassays.
  • aqueous solution dissolvable elements include polyvinyl alcohol (PVA), chitosan, polyethylene oxide (PEO), hydroxypropyl methylcellulose phthalate (HPMCP), pullulan, or methyl acrylate copolymers or the like.
  • PVA polyvinyl alcohol
  • PEO polyethylene oxide
  • HPPMCP hydroxypropyl methylcellulose phthalate
  • pullulan or methyl acrylate copolymers or the like.
  • the aqueous solution dissolvable element may be provided in the form of a film or foil or the like.
  • the aqueous solution dissolvable element is a PVA foil.
  • the aqueous solution dissolvable element is a methyl acrylate copolymer with different acidic or alkaline end groups, which allow for pH-dependent solubility to keep the element stable in breath with pH 7 and dissolve it rapidly at pH above 7.
  • Non-limiting examples of suitable filter elements include filters based on nonwoven fibers such as nanofiber mats or melt-blown fibers, woven materials, fiberglass, electrostatic filters, filter membranes or the like.
  • the filter can be non-dis solvable, partially or fully dissolvable in aqueous solution. Like for the aqueous solution dissolvable element the dissolution can also be triggered by a change in pH.
  • Non-limiting examples for fiber production include electrospinning, melt blowing, blow spinning, wet spinning, direct drawing, centrifugal spinning, force spinning, touch- and brush-spinning, template synthesis, self-assembly, isolating fibers from plants or wood.
  • the filter element is a two-layer arrangement of two non-dissolvable polymer nanofiber mats on polymer support meshes.
  • such a device provides a portable, hand-held, highly efficient, point-of-care collection and elution system for pathogen biomarkers like nucleic acids and antigens from human breath aerosol particles that is fully disposable and does not rely on complex instruments.
  • the elution is preferably done by connecting the sampling device to an elution device such as an elution tube containing an aqueous solution and turning it upside down to dissolve the aqueous solution dissolvable element as an effect of gravitational force.
  • the aqueous solution is a stabilizing and/or inactivating transport buffer containing TRIS, ethylenediaminetetraacetic acid (EDTA), guanidine thiocyanate, guanidine hydrochloride, HEPES, Universal Transport Medium (UTM), liquid amies transport medium, Tween 20, Triton XI 00, tri s(2-carboxy ethyl )phosphine (TCEP), sodium chloride, phosphate-buffered saline, Hank’s balanced salt solution, bovine serum albumin, L-cysteine, gelatin, sucrose, glutamic acid, vancomycin, amphotericin B, colistin, phenol red, sodium hydroxide, isopropanol or a combination thereof.
  • TRIS ethylenediaminetetraacetic acid
  • EDTA ethylenediaminetetraacetic acid
  • guanidine thiocyanate guanidine hydrochloride
  • HEPES Universal Transport Medium
  • the elution device is a standard clinical lab tube and therefore highly compatible with standard workflows of centralized labs. This not only speeds up the entire process from the point at which the aerosol sample is taken up to the point at which the sample undergoes clinical analysis, but also requires fewer logistic steps and minimizes the contamination risk of the biological sample.
  • the immediate elution of the pathogen and pathogen biomarkers with a stabilizing aqueous solution right after the collection of the aerosol particles with the sampling device preserves the viability of the pathogen and stabilizes the pathogen biomarkers for transportation.
  • inactivation of the pathogen for safe transportation is desirable which can be achieved by an inactivating buffer that kills the pathogen but preserves the biomarkers.
  • a non-limiting example is the use of guanidine thiocyanate containing buffer which inactivates the pathogen but preserves nucleic acids for transportation of the sample at ambient temperature.
  • the elution device containing the collected aerosol particles is shipped to a centralized laboratory for testing.
  • such a collection and elution system preferably includes relatively few parts for economical manufacturing.
  • the sampling device preferably outputs a concentrated pathogen biomarker sample with compatibility with a variety of different assays, analyzers and methods for the detection of respiratory pathogens present anywhere in the respiratory tract, including without limitation the upper respiratory tract and/or the lower respiratory tract.
  • the sampling device does not require powered equipment for collection and elution.
  • Analyzers and assays used with the present invention can be point-of-care systems or centralized lab systems.
  • Non-limiting examples of assays and detection methods include immunoassays, molecular assays including all nucleic acid amplification tests (NAATs such as PCR, isothermal amplification), DNA hybridization assays, CRISPR-based assays, sequencing assays, or growth assays.
  • NAATs nucleic acid amplification tests
  • DNA hybridization assays CRISPR-based assays
  • sequencing assays or growth assays.
  • Figure 1 A-B are exemplary, non-limiting perspective cut-away side elevation views of the sampling device with (A) a large accelerator opening and (B) an alternative, optional embodiment of the present invention having a nozzle arrangement as an accelerator.
  • Figure 2 A-B are exemplary, non-limiting perspective cut-away side elevation views of the filter assembly illustrating (A) the collection of aerosol particles during aerosol sample collection and (B) the centric opening that forms upon dissolution of the aqueous solution dissolvable element upon elution.
  • Figure 3 A-C are exemplary, non-limiting perspective cut-away views of a detail of the filter assembly shown in Figure 2 illustrating (A) the filter element and the aqueous solution dissolvable element (B) the centric opening that forms upon dissolution of the aqueous solution dissolvable element upon contact with aqueous solution upon elution, and (C) an example of a preferred embodiment with two stacked filters.
  • Figure 4 is an exemplary, non-limiting perspective cut-away side elevation view of the system illustrating the sampling device, elution device, and the aqueous solution during elution.
  • Figure 5 shows an exemplary, non-limiting perspective cut-away side elevation view of the previously described sampling device integrated in a face mask.
  • Figure 6 A-B show results from limit of detection experiments with the sampling device in combination with PCR.
  • FIG. 7A-B show aerosol filter efficiency results of the sampling device.
  • Figure 8 shows results of breathing resistance measurements from the sampling device.
  • references in the specification to “one embodiment,” “an embodiment,” “an example embodiment,” etc. indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases do not necessarily refer to the same embodiment. Further, when a particular feature, structure or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to effect such feature, structure or characteristic in connection with other embodiments whether or not explicitly described.
  • the sampling device and elution device can also be in a microfluidic arrangement integrated within a microfluidic assay with a detection system for performing a variety of tests, such as immunoassays, isothermal amplification assay, PCR, DNA hybridization, sequencing etc.
  • the test cartridge integrates all of the components necessary to perform such tests into a single, disposable package.
  • the test cartridge may be configured to be analyzed by an external detector to read the assay signal which has a connection to a data entry, data processing and presentation system which provides data related to the reactions that take place within the test cartridge.
  • sampling device it may well be understood and therefore named as a collector, as it collects aerosol particles or particulate matter contained in a breath sample of a human or animal or in an environmental or room air sample. At the time the particles or particulate matter are collected, they are only suspected to contain respiratory pathogens and/or related biomarkers. Tests carried out thereafter will provide qualitative positive or negative confirmation or quantification of the pathogen or pathogens.
  • the sampling device serves the purpose to sample respiratory pathogens and/or biomarkers possibly existing in the collected particles or particulate matter.
  • aqueous solution dissolvable element and/or the filter element are located on a filter holder and/or support meshes that are not dissolvable by the aqueous solution.
  • the particles which originate from the aerosol and which are sorbed by the aqueous solution dissolvable element and filtered by the filter element are washed out or eluted from the substrate by dissolution of the aqueous solution dissolvable element and/or eluting particles from the filter element and or full or partial dissolution of the filter element.
  • Sorbtion by the aqueous solution dissolvable element and/or filter may include adsorption and/or absorption and/or binding and/or filtering.
  • FIG. 1A-B show exemplary, non-limiting embodiments of the sampling device. Components with the same numbers in Figure 1 A and IB have the same or at least similar function.
  • the sampling device 1 of Figure 1 A-B comprises a tubular housing 3 having a flow inlet 4 at one end and a flow outlet 5 at the other end opposite the flow inlet 4. Aerosol particles 2 flow along an airflow path 6 from the flow inlet 4 towards the flow outlet 5 and are captured inside the filter assembly 7 with the aqueous solution dissolvable element 8 and with the filter element 9.
  • the tubular housing 3 is preferably of a two-piece design. The two parts are held together by means of a threaded or clamped engagement of the two parts. To this end, an external thread provided at the upper end of the lower part engages an internal thread provided at the lower end of the upper part.
  • An aqueous solution dissolvable element 8 and a ring-shaped filter element 9 are supported by a filter holder 12 which extends into tubular housing 3 in a perpendicular plane.
  • an accelerator 17 Upstream of the aqueous solution dissolvable element 8 is provided an accelerator 17.
  • the accelerator 17 preferably includes one or a plurality of nozzles 18 which act as an accelerator 17 as the nozzles 18 accelerate the aerosol particles 2a as they flow through the nozzles 18.
  • the nozzles 18 of the accelerator 17 are preferably equidistantly spaced apart from each other across the inner diameter of the tubular housing 3.
  • the sum of the area of all nozzle openings in the accelerator 17 is in the range from 20 to 200 mm 2 .
  • the aqueous solution dissolvable element 8 and the filter element 9 are held in position by a retainer element 11.
  • a thread 16 Upstream of the accelerator 17 is provided a thread 16 which may be used for the purpose of engaging a closure 20 (shown in Figure 4) with the thread to close off the flow inlet 4.
  • the thread 16 may be an internal or external thread depending on the type of closure.
  • the thread 16 may be an external thread provided on the inner surface of the housing 3 to introduce a threaded plug or lid to close off the flow inlet 4.
  • the same thread 16 might be used to optionally connect the sampling device to a face mask 22 using a clamping ring 21 for long sampling times as illustrated in Figure 5.
  • Another thread 13 is provided downstream of the aqueous solution dissolvable element 8 and the filter element 9 which may be used to screw into the tubular housing 3 an elution device 14 containing aqueous solution 15 to dissolve the aqueous solution dissolvable element 8 and eluate the collected aerosol particles on said aqueous solution dissolvable element 8 or on said filter element 9 as shown in Figure 4.
  • the elution device 14 is a tube with a closed end and an open end opposite the closed end.
  • An external thread is provided in proximity of the open end of the elution device 14, which may be brought into engagement with the internal thread 13 provided downstream of the aqueous solution dissolvable element 8 that dissolves upon contact with the aqueous solution to build an opening 10 inside the sampling device 1.
  • the sampling device 1 may well be provided with any type of engagement means to releasably engage the elution device 14 with the housing 3 of the sampling device 1.
  • engagement means may be a clamping means, piercing means, such as the needle, a threaded engagement means, such as shown in Figure 1, or other types of connecting or fastening means that are suitable to releasably engage the elution device 14 with the tubular housing 3 of the sampling device 1 in order to provide a fluidic communication pathway between the elution device 14 and the interior of the housing 3 of the sampling device 1.
  • the sampling device 1 shown in Figure 1 and Figure 4 is optimized towards efficient collection of pathogens present in human breath aerosol particles with low breathing resistance and high aerosol particle filter efficiency and subsequent dissolution of the aqueous solution dissolvable element 8 followed by complete elution of the aerosol particles from filter element 9 through submerging said filter element 9 due to formation of an opening 10 and subsequent easy collection of the sample in an elution device 14 such as a standard lab tube.
  • Figure 2A-B show details of the filter assembly 7 of Figure 1 A in a perspective, cut-away side elevation.
  • Figure 2A illustrates the filter assembly 7 during collection of aerosol particles 2 and/or molecules and/or biomarkers and/or pathogens.
  • the sampling device is designed to collect such molecules and/or structures and/or biomarkers and/or pathogens present in human breath aerosol particles.
  • Aerosol containing aerosol particles 2 passes through flow path 6.
  • non- gaseous components of the breath are concentrated at the aqueous solution dissolvable element 8.
  • the dissolvable material 8 preferably comprises a aqueous solution dissolvable element which is held in position by a retainer element 11.
  • the aerosol can be a breath sample from a human or animal or an environmental sample or the like. If a respiratory pathogen is present in the lungs, throat, mouth and/or other parts of the respiratory tract, molecules and/or structures and/or biomarkers from such a pathogen or the entire pathogen itself are expected to be present in the aerosol particles 2.
  • the aqueous solution dissolvable element 8 preferably comprises an airtight material through which such particles cannot pass, such as a foil, membrane, film, or the like such that the larger particles of the aerosol become trapped or are deposited on said dissolvable material 8 due to aerosol particles 2 inertia or interception.
  • This first aerosol particle collection stage with the aqueous solution dissolvable element 8 can help to preserve the filter capacity of the second aerosol particle 2 collection stage by removing larger aerosol particles before the aerosol reaches the filter element 9.
  • the filter element 9 is ring-shaped and arranged radially outwardly from the aqueous solution dissolvable element 8.
  • Alternative filter element embodiments include cylindric, conical filters or the like. Both, the filter element 9 and the aqueous solution dissolvable element 8 are kept in place by a retainer element 11 that is clampingly engageable with a filter holder 12.
  • the filter element 9 and the aqueous solution dissolvable element 8 partially overlap to ensure that the entire sample is forced to pass through said filter element 9.
  • the filter element 9 and the aqueous solution dissolvable element 8 are bonded at the intersection with methods like ultrasonic bonding or the like
  • the filter assembly 7 is configured to support collection of such particles in a sufficiently concentrated amount with high filter efficiency, without requiring excessive exhalation force on the part of the subject or low backpressure if a pump is used to sample an environmental aerosol.
  • Subjects having a reduced lung capacity, lung inflammation and/or otherwise unable to produce a great deal of force upon exhalation are able to provide a sufficient sample, due to the concentrating effect of the two collection stages combining the aqueous solution dissolvable element 8 and the filter element 9.
  • the aqueous solution dissolvable element 8 and the filter element 9 are supported by the filter holder 12.
  • the filter holder 12 is configured such that a large enough surface of the aqueous solution dissolvable element 8 is exposed to allow for dissolution of the aqueous solution dissolvable element 8 when brought into contact with an aqueous solution provided by the elution device 14 to form an opening 10 which results in submersion of the filter element 9 in aqueous solution.
  • the sampling device 1 For that purpose, once the elution device 14 is screwed into the sampling device 1, the sampling device 1 together with the elution device 14 is turned upside down, thus causing the aqueous solution to flow out of the elution device 14, into the sampling device 1 and into contact with the aqueous solution dissolvable element 8 by effect of gravitation via the openings in the filter holder 12.
  • a variety of dissolvable polymer materials are available and suitable for use for the aqueous solution dissolvable element 8.
  • suitable dissolvable polymer materials include polyvinyl alcohol (PVA), chitosan, polyethylene oxide (PEO), pullulan, polyvinylpyrrolidone (PVP), polyvinyl acrylic acid (PVAc), poly methacrylic acid (PMAc), methyl acrylate copolymers, hydroxypropyl methylcellulose phthalate (HPMCP), or a combination thereof.
  • PVA polyvinyl alcohol
  • PEO polyethylene oxide
  • pullulan polyvinylpyrrolidone
  • PVP polyvinyl acrylic acid
  • PMAc poly methacrylic acid
  • methyl acrylate copolymers hydroxypropyl methylcellulose phthalate
  • HPMCP hydroxypropyl methylcellulose phthalate
  • Figure 3A-C show details of the filter assembly 7 from Figure 1 and Figure 2.
  • Figure 3 A shows the arrangement of the filter element 9 and the aqueous solution dissolvable element 8 on the filter holder 12 with their partial overlap.
  • Figure 3B shows the centric opening that forms upon dissolution of the aqueous solution dissolvable element 8 upon elution.
  • Figure 3C illustrates a preferred embodiment of two stacked filters.
  • filters are available and suitable for use for the filter element 9.
  • suitable filters include filters based on nonwoven fibers such as nanofiber mats or melt-blown fibers, woven materials, fiberglass, electrostatic filters, filter membranes or the like.
  • the filter element can be non-dissolvable, partially or fully dissolvable in aqueous solution.
  • Non-limiting examples for fiber production include electrospinning, melt blowing, blow spinning, wet spinning, direct drawing, centrifugal spinning, force spinning, touch- and brush-spinning, template synthesis, self-assembly, isolating fibers from plants or wood.
  • the filter element is a two-layer arrangement of two non-dissolvable polymer nanofiber mats on polymer support meshes having a thickness in the range between 40 pm to 500 pm to support the fibers.
  • the support meshes are a poly(hexamethylene adipamide) (PA 6.6) support mesh (such as Sefar Nitex 03- 130/52, Sefar AG, Switzerland).
  • the fibers have a dimeter in the range between 20 nm to 1 pm, preferably 300 nm.
  • the stacking of two filters has the advantage that the upper filter 9a can compensate small defects or inconsistencies of the lower filter 9b and vice versa to achieve high aerosol particle filter efficiencies at low pressure resistance.
  • the aqueous solution dissolvable element 8 may contain agents or detergents to increase stability during collection and improve solubility during elution.
  • agents or detergents include Triton X-100, Tween, SDS, di chlorodiphenyl tri chloroethane (DDT), chaotropic salts, Dithiothreitol (DTT), acids and/or bases, pH buffer salts, beads, or any combinations thereof.
  • the aqueous solution 15 that is introduced with the elution device 14 may contain lysing agents or detergents and may be configured to create a lysate.
  • lysing agents or detergents include Triton X-100, Tween, SDS, di chlorodiphenyl tri chloroethane (DDT), chaotropic salts, Dithiothreitol (DTT), acids and/or bases, pH buffers, beads, solvents, or any combinations thereof.
  • the aqueous solution is a TRIS-EDTA buffer with a pH above 8.0 and directly compatible with nucleic acid amplification tests (NAATs) such as PCR.
  • NAATs nucleic acid amplification tests
  • the tube containing the aqueous solution 15 can be custom made or be a standard centralized laboratory tube containing PCR transport media such as tubes from the cobas PCR Media kit (Roche Diagnostics, Switzerland) or the universal viral transport (UVT) system (Becton Dickinson, USA) or MSwab (Copan, Italy).
  • the elution device 14 contains 2 ml of aqueous solution.
  • Figure 4 shows an exemplary, non -limiting embodiments of the sampling device 1, the elution device 14 and closure 20 such as a lid or plug.
  • sampling device 1 can also be transported and/or stored together with the elution device 14 with the aqueous solution 15 as the aqueous solution may help to stabilize the pathogen and/or biomarkers during storage and/or transportation.
  • the aqueous solution can also inactivate the pathogen for safe transportation and storage
  • Example 1 Evaluation of the sampling device for the collection of Mycobacterium from simulated breath aerosols with elution and detection using PCR
  • This non-limiting Example relates to an optimized illustrative sampling device for the collection of Mycobacterium aerosol particles with elution using the elution device and subsequent detection using polymerase chain reaction (PCR).
  • PCR polymerase chain reaction
  • PVA polyvinyl alcohol
  • PAN Polyacrylonitrile
  • the sampling device housing was washed an autoclaved.
  • the PVA film and two stacked filter elements were positioned on the filter holder and fixed with the retainer element.
  • the sampling device design is illustrated in Figure 1 A, the filter assembly in Figure 2, and the details of the filter assembly in Figure 3C. Simulated mycobacterial aerosols
  • Mycobacterium bovis BCG stocks (7.19xl0 6 cfu/ml) were serially diluted in lx TE buffer pH 8 (10 mM Tris, 1 mM EDTA) to achieve 10, 50, 100, and 500 cfu per 70 pl.
  • the TE buffer but without BCG was used to generate “negative” samples.
  • Approximately 70 pl of these BCG suspensions with different cell concentrations or the negative sample were nebulized with a Cirrus2 nebulizer (Inter surgical, UK) using HEPA-filtered air at 6 l/min to achieve BCG inputs of 0 (“negative”), 10 cfu, 50 cfu, 100 cfu, and 500 cfu in the aerosol.
  • the nebulizer outlet was connected to a T-piece to dilute the aerosol with 34 l/min HEPA-filtered air to achieve a total mass flow of 40 l/min. Air flow rates were controlled with two SFC5500 mass flow controllers (Sensirion, Switzerland) controlled by a custom-made Lab View software (National Instruments, Switzerland).
  • the output of the T-piece with the diluted aerosol was connected to the inlet of the sampling device for 15 seconds of aerosol sampling per experiment. 6 repeats per concentration level (0, 10, 50, 100, 500 cfu BCG) were performed with the sampling device. In addition 6 repeats were performed with the sampling device after exposure to 20 human breaths of a healthy subject at the 500 cfu BCG level to assess the stability of the sampling device after exposure to human breath.
  • an elution device which is a standard laboratory tube containing 2 ml of lx TE buffer pH 8 (10 mM Tris, 1 mM EDTA) was connected to the sampling device via the thread on the outlet side.
  • the sampling device was closed with a plug via the thread on the inlet side.
  • the arrangement was turned upside-down for 4 minutes so that the TE buffer comes into contact with the aqueous solution dissolvable element to form an opening upon dissolution to elute the collected BCG bacteria from the filter element and the dissolvable material.
  • the eluate runs into the elution device/tube and the sampling device was removed. The eluate in the tube was used for subsequent analysis with PCR.
  • DNA was extracted from the entire eluate of approximately 1.8 ml in the tube by using a spin column protocol of the Qiagen QIAamp DNA minikit (Qiagen, Switzerland) as described in the handbook. 9 pL of extracted DNA was subsequently used for PCR on a QuantStudio5 qPCR cycler (ThermoFisher, Switzerland) to amplify IS67/d, a gene unique to M. tuberculosis complex. Analysis
  • Table 1 shows the results of 36 aerosol experiments for the sampling device and elution device in combination with the detection using PCR.
  • Figure 6A shows PCR Ct values of all positive samples and a clear trend towards longer Ct values for aerosol samples with lower BCG input. There was no significant difference in the Ct’s of collectors pre- and post-exposure to human breath suggesting that the sampling device is sufficiently stable during collection.
  • Table 1 shows the probability of positivity per cfu concentration level. The negative aerosol collected with the sampling device and eluted with the elution device remained negative for all samples (0/6).
  • An LOD of 12 cfu BCG was determined using the probit model based on binary logistic regression fitted through the tested concentration with the LOD defined as the cfu BCG input where the probability of sample positivity reaches 95%.
  • the probit curve is shown in Figure 6B.
  • Example 1 This non-limiting Example relates to an illustrative sampling device from Example 1 for the collection of aerosol particles.
  • the sampling device was produced as described in Example 1 and is illustrated in Figure 1A.
  • the sampling device is integrated into a face mask as illustrated in Figure 5.
  • Filter efficiency was tested according to European Norm EN 13274-7 using a PMFT 1000 test system (Palas, Germany) using oil aerosol particles and a Promo 1000 aerosol photometer (Palas, Germany) for the measurement of aerosol size distribution.
  • Figure 7A shows filter efficiency results of 13 independent filter efficiency experiments with the sampling devices integrated in FFP2 face masks for aerosol sizes between 100 nm and 1.44 pm. Filter efficiency is consistently above 90% for aerosol sizes above or equal to 300 nm. The cumulative filter efficiency in the aerosol size range between 300 nm and 2.2 pm is 97.4 % (95% Confidence Interval 96.7 — 98.1%).
  • Figure 7B shows results of six independent filter efficiency experiments of the sampling devices integrated in FFP2 face masks post exposure to 20 human exhalations into the sampling device. It shows that filter efficiency remains above 90% post exposure to human exhalate suggesting that the sampling devices maintain their filter efficiency after exposure to human breath.
  • the cumulative filter efficiency post exposure to human breath in the aerosol size range between 300 nm and 2.2 pm is 97.0 % (95% CI: 95.5—98.5%).
  • Example 3 breathing resistance of the sampling device from Example 1
  • This non-limiting Example relates to an illustrative sampling device from Example 1.
  • Pressure drop measurement Breathing resistance of three independent sampling devices from Example 1 were measured by determining the pressure drop at different air mass flow rates between 10 and 80 1/min. Pressure drop over the sampling device was measured using a PREMASGARD 1115-1 LCD (S+S Regeltechnik, Germany) differential pressure sensor. Air flow rates were controlled with a SFC5500 mass flow controller (Sensirion, Switzerland).
  • Figure 8 shows the pressure drops from three sampling devices at different air mass flow rates.
  • the average differential pressure (or breathing resistance) of the sampling device at 40 1/min was 1142 Pa.
  • the average differential pressure of the sampling device at 50 l/min was 1481 Pa.
  • the average differential pressure of the sampling device at 60 1/min was 1837 Pa. This breathing resistance is sufficiently low to collect exhaled breath without exposing the patient to stress.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

L'invention concerne un dispositif et un système pour collecter des particules d'aérosol contenues dans un échantillon d'aérosol et préparer l'échantillon en vue d'une analyse. L'aérosol peut être l'haleine d'une personne ou d'un animal ou un échantillon environnemental. Dans au moins certains modes de réalisation, la présente invention concerne un dispositif et un système servant à collecter, conserver, concentrer des particules d'aérosol provenant d'aérosols et libérer les particules d'aérosol dans une solution aqueuse en vue d'une analyse avec des dosages immunologiques et des dosages moléculaires pour la détection d'agents pathogènes. Le dispositif d'échantillonnage comprend un ensemble de filtrage, l'ensemble de filtrage comprenant un élément soluble en solution aqueuse et un élément filtrant installé dans un boîtier du dispositif d'échantillonnage, dans le trajet d'écoulement des échantillons d'aérosol, qui sorbe et/ou filtre les particules d'aérosol. Après la collecte, lors du raccordement amovible d'un dispositif d'élution pour introduire une solution aqueuse dans le boîtier, l'élément soluble en solution aqueuse est dissous et l'élément filtrant est immergé dans la solution aqueuse pour récupérer les particules d'aérosol d'une manière très efficace.
PCT/EP2023/079951 2022-10-27 2023-10-26 Dispositif et système de collecte de particules d'aérosol et de préparation de l'échantillon pour analyse Ceased WO2024089183A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CHCH001271/2022 2022-10-27
CH12712022 2022-10-27

Publications (1)

Publication Number Publication Date
WO2024089183A1 true WO2024089183A1 (fr) 2024-05-02

Family

ID=84358041

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2023/079951 Ceased WO2024089183A1 (fr) 2022-10-27 2023-10-26 Dispositif et système de collecte de particules d'aérosol et de préparation de l'échantillon pour analyse

Country Status (1)

Country Link
WO (1) WO2024089183A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025262239A1 (fr) * 2024-06-19 2025-12-26 Pexa Ab Système et procédé de collecte de particules dans de l'air expiré

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1377815A2 (fr) 2001-04-11 2004-01-07 Rapid Biosensor Systems Limited Systeme de mesure biologique
US20120045752A1 (en) * 2010-08-17 2012-02-23 Reseach Triangle Institute Fiber sampler for recovery of bioaerosols and particles
WO2013132085A1 (fr) 2012-03-08 2013-09-12 Sensa Bues Ab Dispositif de prélèvement portable et procédé pour détecter des biomarqueurs dans l'air expiré
US20130273520A1 (en) 2012-04-16 2013-10-17 Edward Sobek Composition, device, and method for biological air sampling
US20130319239A1 (en) * 2011-02-22 2013-12-05 Hitachi, Ltd. Device and Method for Collecting Airborne Microorganisms
US20150377748A1 (en) 2014-06-27 2015-12-31 Pulse Health Llc Breath analysis system
WO2017187141A1 (fr) 2016-04-25 2017-11-02 Owlstone Medical Limited Procédé de collecte d'une partie sélective de l'haleine d'un sujet
US10080857B2 (en) 2013-03-12 2018-09-25 Deton Corp. System for breath sample collection and analysis
US10413215B2 (en) 2012-04-12 2019-09-17 Enose Holding B.V. Mobile device and method for analysing breath samples
US20200300876A1 (en) 2019-03-21 2020-09-24 Hound Labs, Inc. Biomarker detection from breath samples
WO2021242907A1 (fr) 2020-05-26 2021-12-02 Al2 Impact, Inc. Compositions, dispositifs et procédés permettant de tester des surfaces inanimées, des groupes et des individus pour une infection pathogène
WO2022079195A1 (fr) 2020-10-14 2022-04-21 Imec Vzw Dispositif de collecte pour la collecte de particules, collecteur d'échantillon et instrument d'analyse
WO2022155392A1 (fr) * 2021-01-13 2022-07-21 Michael Wohl Dispositifs et procédés de collecte et d'analyse d'échantillons de bioaérosol

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1377815A2 (fr) 2001-04-11 2004-01-07 Rapid Biosensor Systems Limited Systeme de mesure biologique
US20120045752A1 (en) * 2010-08-17 2012-02-23 Reseach Triangle Institute Fiber sampler for recovery of bioaerosols and particles
WO2012024407A1 (fr) 2010-08-17 2012-02-23 Research Triangle Institute Echantillonneur de fibres utilisé pour le recueil de bioaérosols et de particules
US20130319239A1 (en) * 2011-02-22 2013-12-05 Hitachi, Ltd. Device and Method for Collecting Airborne Microorganisms
WO2013132085A1 (fr) 2012-03-08 2013-09-12 Sensa Bues Ab Dispositif de prélèvement portable et procédé pour détecter des biomarqueurs dans l'air expiré
US10413215B2 (en) 2012-04-12 2019-09-17 Enose Holding B.V. Mobile device and method for analysing breath samples
US20130273520A1 (en) 2012-04-16 2013-10-17 Edward Sobek Composition, device, and method for biological air sampling
US10080857B2 (en) 2013-03-12 2018-09-25 Deton Corp. System for breath sample collection and analysis
US20150377748A1 (en) 2014-06-27 2015-12-31 Pulse Health Llc Breath analysis system
WO2017187141A1 (fr) 2016-04-25 2017-11-02 Owlstone Medical Limited Procédé de collecte d'une partie sélective de l'haleine d'un sujet
US20200300876A1 (en) 2019-03-21 2020-09-24 Hound Labs, Inc. Biomarker detection from breath samples
WO2021242907A1 (fr) 2020-05-26 2021-12-02 Al2 Impact, Inc. Compositions, dispositifs et procédés permettant de tester des surfaces inanimées, des groupes et des individus pour une infection pathogène
WO2022079195A1 (fr) 2020-10-14 2022-04-21 Imec Vzw Dispositif de collecte pour la collecte de particules, collecteur d'échantillon et instrument d'analyse
WO2022155392A1 (fr) * 2021-01-13 2022-07-21 Michael Wohl Dispositifs et procédés de collecte et d'analyse d'échantillons de bioaérosol

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
DENKINGER, JID, vol. 211, 2015
FENNELLY ET AL., AM J RESPIR CRIT CARE MED, vol. 169, no. 5, 2004, pages 604
FENNELLY ET AL., CHEST, vol. 157, no. 3, 2020, pages 540
GAL ET AL., PLOS ONE, vol. 13, no. 8, 2018, pages e0200531
GRALTON ET AL., J MED VIROL, vol. 85, no. 12, 2013, pages 2151
KIM ET AL., CLIN INFECT DIS, vol. 63, no. 3, 2016, pages 363
KULKARNI ET AL., AM J RESPIR CRIT CARE MED, vol. 194, no. 3, 2016, pages 308
LIU ET AL., NATURE, vol. 582, no. 7813, 2020, pages 557
RILEYWELLS, AM J HYG, vol. 70, 1959, pages 185
VOS ET AL., LANCET, vol. 396, no. 1082, 2020, pages 1204
WANG ET AL., SCIENCE, vol. 373, no. 6558, 2021
YAN ET AL., PROC NATL ACAD SCI., vol. 115, no. 5, 2018, pages 1081

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025262239A1 (fr) * 2024-06-19 2025-12-26 Pexa Ab Système et procédé de collecte de particules dans de l'air expiré

Similar Documents

Publication Publication Date Title
US20240215961A1 (en) Device, system and method for collecting and eluting aerosol particles from human breaths for analysis
US10080857B2 (en) System for breath sample collection and analysis
CN103119417B (zh) 空气传播的细菌样品收集和分析系统
EP3336515B1 (fr) Échantillonneur d'air portatif comprenant un magasin de filtres pour contenir et positioner lesdits filtres
JP6329164B2 (ja) 気中物質検知装置用のカートリッジ及び気中物質検知装置
US8250903B2 (en) Biological particle collector and method for collecting biological particles
WO2022093876A1 (fr) Masques faciaux multifonctions
JP7778131B2 (ja) 感度を改善するために組み合わされたサンプルを使用するキット及び方法
WO2014118898A1 (fr) Dispositif de détection de substances en suspension dans l'air et cartouche utilisée dans ce dispositif
US20220034763A1 (en) Platform for sampling viral particles on surfaces, porous structures, and in the air
WO2024089183A1 (fr) Dispositif et système de collecte de particules d'aérosol et de préparation de l'échantillon pour analyse
Feng et al. On-site monitoring of airborne pathogens: recent advances in bioaerosol collection and rapid detection
Ladhani et al. Electrostatic sampling of patient breath for pathogen detection: A pilot study
Zhou et al. Research advances in microfluidic collection and detection of virus, bacterial, and fungal bioaerosols
US20240068054A1 (en) Devices and methods for collecting and analyzing bio-aerosol samples
WO2022221198A1 (fr) Dispositif de collecte d'échantillon d'aérosol
JP2024519891A (ja) サンプル収集デバイス及びシステム
US20200110008A1 (en) Personal sampler for bioaerosol
US20220236147A1 (en) Respiratory disease surveillance systems and methods using high flowrate aerosol capture for rapid on-site analysis
Agranovski Personal sampler for viable airborne microorganisms: main development stages
Parker et al. Review of Field Sampling Technologies for Characterizing Bioaerosols in Compact Spaces
JP2016045056A (ja) 気中特定粒子の固定装置、気中特定粒子検知装置、マスク及び特定粒子検知方法
KR20230159376A (ko) 바이오에어로졸 샘플을 채집하고 분석하는 기기 및방법
JP2024513093A (ja) サンプル収集デバイス、システム、及び方法
EP4012042A1 (fr) Ensemble pour l'enrichissement des micro-organismes présents dans l'aérosol comprenant les petites gouttelettes d'air respiratoire d'un sujet et procédé d'enrichissement de micro-organismes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23793900

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23793900

Country of ref document: EP

Kind code of ref document: A1